BullFrog AI Holdings BFRG
NASDAQ BFRG
$0.50 +0.01 (+2.04%)
At close: Sep 4, 2026 · 4:00 PM EDT

BullFrog AI Holdings (BFRG) Research & Development (2022 - 2026)

BullFrog AI Holdings' (BFRG) quarterly Research & Development came in at $339456.0 in Q2 2026, down 29.32% on a YoY basis from $480297.0 in Q2 2025, and down 14.54% quarter-over-quarter from $397189.0 in Q4 2025.

Analysis

BullFrog AI Holdings (BFRG) Research & Development (2022 - 2026) Analysis & Trends

BullFrog AI Holdings (BFRG) has reported Research & Development for 5 consecutive years, with $339456.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Research & Development fell 29.32% year-over-year to $339456.0; the trailing twelve-month figure through Jun 2026 stood at $1.6 million (down 29.41% YoY), and the FY2025 full-year result was $1.8 million, down 19.05% from the prior year.
  • Research & Development fell to $339456.0 in Q2 2026 per BFRG's latest filing, from $397189.0 in the prior quarter.
  • Across five years, Research & Development topped out at $590856.0 in Q4 2024 and bottomed at $39421.0 in Q3 2022.
  • Historically, Research & Development has averaged $376726.1 across 5 years, with a median of $380015.0 in 2023.
  • The sharpest annual moves came in 2023 and 2025: Research & Development surged 863.99% in 2023, then slumped 38.93% in 2025.
  • Over 5 years, Research & Development stood at $160895.0 in 2022, then surged by 154.2% to $408995.0 in 2023, then jumped by 44.47% to $590856.0 in 2024, then sank by 32.78% to $397189.0 in 2025, then dropped by 14.54% to $339456.0 in 2026.
  • According to Business Quant data, Research & Development over the past three periods registered $339456.0, $397189.0, and $345992.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 1.87 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 1.76 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 993.80 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 1.63 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -486.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 651.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 413.13 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 529.60 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 210.03 Mn
10 BullFrog AI Holdings 9.27 Mn 2.35 Mn 106,899.00 339,456.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 339,456.00
Dec 31, 2025 397,189.00
Sep 30, 2025 345,992.00
Jun 30, 2025 480,297.00
Mar 31, 2025 576,260.00
Dec 31, 2024 590,856.00
Sep 30, 2024 566,584.00
Jun 30, 2024 513,699.00
Mar 31, 2024 552,126.00
Dec 31, 2023 408,995.00
Sep 30, 2023 380,015.00
Jun 30, 2023 273,671.00
Mar 31, 2023 369,933.00
Dec 31, 2022 160,895.00
Sep 30, 2022 39,421.00
Jun 30, 2022 92,671.00
Mar 31, 2022 316,283.00